These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4411256)

  • 21. [Therapy of arterial occlusive disease of the lower limbs using Tebonin].
    Kandziora J
    Z Allgemeinmed; 1973 May; 49(14):682-5. PubMed ID: 4754639
    [No Abstract]   [Full Text] [Related]  

  • 22. [Discontinuation of oral anticoagulant therapy following fibrinolytic treatment in arterial occlusive disease].
    Engelken HJ; Martin M
    Med Welt; 1974 Jun; 25(25):1122-4. PubMed ID: 4418430
    [No Abstract]   [Full Text] [Related]  

  • 23. [Defibrination in the therapy of arterial occlusive diseases].
    Böhme H
    ZFA (Stuttgart); 1978 Nov; 54(32):1644-7. PubMed ID: 735319
    [No Abstract]   [Full Text] [Related]  

  • 24. [Use of aerosol preparations in external therapy of patients with eczema].
    Somov BA; Ivanov VV
    Vestn Dermatol Venerol; 1974 Oct; 0(10):52-4. PubMed ID: 4432617
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparative effectiveness of drug preparations given by intraarterial regional infusion to patients with occlusion of the distal arterial bed].
    Silaev IuS; Avchenko MT; Gus'kov OI
    Klin Med (Mosk); 1984 Jun; 62(6):89-93. PubMed ID: 6471805
    [No Abstract]   [Full Text] [Related]  

  • 26. [A new peripheral vasodilator agent. Personal experience with naphtidrofuryl].
    Romero RL; Vives C; Pastor C; Valdivia Velarde H; Basso G; Bordone JC
    Prensa Med Argent; 1970 May; 57(11):537-42. PubMed ID: 5454084
    [No Abstract]   [Full Text] [Related]  

  • 27. [Results obtained with the glucofuranoside (Glivenol) in several oftalmic diseases (author's transl)].
    Gil Del Río E
    Rev Esp Otoneurooftalmol Neurocir; 1975; 33(193):123-9. PubMed ID: 1215629
    [No Abstract]   [Full Text] [Related]  

  • 28. [Results of treatment with ancrod (Arwin) in 21 patients with chronic arterial occlusive disease].
    Rosendo A; Sala Planell E; Latorre J; Marinello J; Olba L; Rutllant ML
    Rev Clin Esp; 1982 Mar; 164(5):313-6. PubMed ID: 7100546
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinico-instrumental evaluation of ciclonicate in the therapy of obliterating arteriopathies of the lower extremities in Fontaine's stage II].
    Feliciotti F; De Carolis G; Mariotti C; Mingolla F
    Ann Ital Chir; 1983; 55(5):493-7. PubMed ID: 6673630
    [No Abstract]   [Full Text] [Related]  

  • 30. [Drug therapy of arterial occlusive disease].
    Diehm C; Heidrich H; Spengel F; Schulte KL; Theiss W
    Internist (Berl); 2000 Dec; 41(12):1416-22. PubMed ID: 11189078
    [No Abstract]   [Full Text] [Related]  

  • 31. [Defibrination with ancrod (arvin) in peripheral arterial occlusive diseases. Principle, indications, contraindications technic and course].
    Heidrich H
    ZFA (Stuttgart); 1978 Nov; 54(32):1648-51. PubMed ID: 735320
    [No Abstract]   [Full Text] [Related]  

  • 32. [Drug therapy of arterial diseases. A study with Trental 400].
    Tannenberg G
    Fortschr Med; 1980 Dec; 98(45):1795-8. PubMed ID: 7461576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Drug therapy of peripheral arterial occlusive diseases in the lower extremities using Tebonin].
    Perinović M; Vasiljević M; Grujić M
    Ther Ggw; 1973 Mar; 112(3):434-6 passim. PubMed ID: 4700951
    [No Abstract]   [Full Text] [Related]  

  • 34. [New criteria for the objectivation of drug therapy in arterial occlusive disease].
    von Ungern-Sternberg A; Schuster CJ
    Verh Dtsch Ges Inn Med; 1975; 81():879-82. PubMed ID: 1229613
    [No Abstract]   [Full Text] [Related]  

  • 35. [Long term results of intraarterial infusion therapy in peripheral arterial occlusive diseases].
    Hild R; Spaan G; Stein U
    Med Welt; 1981 Apr; 32(14):448-51. PubMed ID: 7219157
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effects of (naphthyl 1)-3 tetrahydrofuryl-2 propionate of diethylamino 2 ethyl on arteries of medium and small calibre. Analysis executed on first and second derivative of peripheral segmental plethysmogram studied in subjects affected by sclerotic obliterating arterial disease].
    Tardito E; Azzolini A; Agus GB; Grassi T
    Minerva Cardioangiol; 1973 Sep; 21(9):573-80. PubMed ID: 4745000
    [No Abstract]   [Full Text] [Related]  

  • 37. [Controlled study on the effect of a new substance in peripheral arterial diseases].
    Poti R; Megha A; Pini M; Bulletti G
    Minerva Cardioangiol; 1974; 22(7-8):574-87. PubMed ID: 4605589
    [No Abstract]   [Full Text] [Related]  

  • 38. [Piribedil in arterial diseases].
    Cristol R; Arnaud F
    Nouv Presse Med; 1974 Nov 30-Dec 14; 3(41-43):2573-4. PubMed ID: 4619431
    [No Abstract]   [Full Text] [Related]  

  • 39. [Conservative therapy of arterial occlusive diseases. Double-blind study on the effect of butalamine hydrochloride].
    Seboldt H
    Fortschr Med; 1980 Feb; 98(7):257-60. PubMed ID: 6767648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of baralgin on the indices of hemodynamics and acid-base equilibrium in patients with occlusive lesions of the arterial vessels].
    Danilenko MV; Timchuk ID; Ivaniushko VL; Pavlova OV
    Vrach Delo; 1983 Mar; (3):63-5. PubMed ID: 6858107
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.